Z

Zomedica Corp
AMEX:ZOM

Watchlist Manager
Zomedica Corp
AMEX:ZOM
Watchlist
Price: 0.055 USD Market Closed
Market Cap: 53.9m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ZOM stock under the Base Case scenario is 0.168 USD. Compared to the current market price of 0.055 USD, Zomedica Corp is Undervalued by 67%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZOM Relative Value
Base Case
0.168 USD
Undervaluation 67%
Relative Value
Price
Z
Worst Case
Base Case
Best Case

Valuation Multiples

2
P/S
P/S
Price to Sales
2
vs History
77
vs Industry
43
Median 3Y
6.9
Median 5Y
6.9
Industry
2.2
Forward
1.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-9.5
Median 5Y
-10.1
Industry
21.5
Forward
-1.1
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-12.3
Median 5Y
-12.5
Industry
13.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-6.1
Median 5Y
-9.4
Industry
20.1
More Details
0.3
P/B
P/B
Price to Book Value
0.3
vs History
96
vs Industry
81
Median 3Y
0.7
Median 5Y
0.8
Industry
2.1
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
2.5
Median 5Y
2.5
Industry
2.3
Forward
-0.8
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
3.6
Median 5Y
3.2
Industry
4.8
More Details
0.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
0.8
vs History
0
vs Industry
56
Median 3Y
-2.5
Median 5Y
-2.9
Industry
11.5
More Details
0.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
0.6
vs History
1
vs Industry
52
Median 3Y
-2.1
Median 5Y
-2.4
Industry
15.7
Forward
0.4
More Details
1
EV/OCF
EV/OCF
Enterprise Value to OCF
1
vs History
0
vs Industry
57
Median 3Y
-3.8
Median 5Y
-4.2
Industry
13.6
More Details
0.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
0.7
vs History
0
vs Industry
46
Median 3Y
-2.2
Median 5Y
-3.3
Industry
17.3
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
Median 3Y
0.4
Median 5Y
0.6
Industry
1.8
More Details

Multiples Across Competitors

ZOM Competitors Multiples
Zomedica Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Zomedica Corp
AMEX:ZOM
53.9m USD 2 -0.9 0.8 0.6
US
Abbott Laboratories
NYSE:ABT
229.2B USD 5.4 17 22 31.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
198B USD 22.7 80 64.5 78.5
US
Boston Scientific Corp
NYSE:BSX
155.2B USD 8.8 76.4 36 50.1
US
Stryker Corp
NYSE:SYK
145.6B USD 6.3 50.9 25.2 30.4
IE
Medtronic PLC
NYSE:MDT
104.4B USD 3.1 22.4 12.6 18
DE
Siemens Healthineers AG
XETRA:SHL
52.8B EUR 2.3 25.3 14.2 19.6
US
Becton Dickinson and Co
NYSE:BDX
49.7B USD 2.4 32.7 13.1 24.5
US
Edwards Lifesciences Corp
NYSE:EW
45.2B USD 8.2 10.8 24.8 27.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.5B USD 10.6 46.4 32.9 36.8
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
279.5B CNY 7.9 25.1 22 22

See Also

Summary
ZOM intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZOM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZOM stock valuation using valuation multiples.
Wall Street Estimates
ZOM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZOM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 257,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.